Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dutasteride effects on intraprostatic DHT prior to TURP
NCT00062790Phase 4Completed
- Sponsor
- GSK
- Start
- Oct 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in benign prostatic hyperplasia (BPH) comparing Dutasteride Arm with Placebo Arm (2 arms). Primary endpoint: Prostate tissue content of dihydrotestosterone at 3 months. Started Oct 2003; status: completed.
02
Drugs
dutasteride
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on NCT00062790.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00062790.